The Author(s) 2014. This article is published with open access at Springerlink.com Abstract There is an opportunity to improve outcomes for ovarian cancer (OC) through advances in risk stratifi-cation, early detection and diagnosis. A population-based OC genetic risk prediction and stratification program is being developed. A previous focus group study with indi-viduals from the general population showed support for the proposed program. This qualitative interview study explores the attitudes of women at high risk of OC. Eight women participated in one-on-one, in-depth, semi-struc-tured interviews to explore: experiences of learning of OC risk, risk perceptions, OC knowledge and awareness, and opinions on risk stratification approach. There...
Epithelial ovarian cancer (EOC) is a heterogeneous disease with a major heritable component. The dif...
Background: Ovarian cancer (OC) is expected to cause 239,000 new cases and 152,000 deaths globally e...
Objective: Ovarian cancer is the leading cause of gynecological death in the United States, and 14% ...
This study assessed the sociodemographic, medical and psychological predictors of accuracy of percei...
Risk stratification using genetic and/or other types of information could identify women at increase...
Risk stratification using genetic and/or other types of information could identify women at increase...
Abstract Background Ovarian cancer is usually diagnosed at a late stage when outcomes are poor. Pers...
Background: In U.S. women, lifetime risk of ovarian cancer is 1.37%, but somewomen are at a substant...
Abstract Background Risk stratification using genetic and other types of personal information could ...
Unselected population-based personalised ovarian cancer (OC) risk assessments combining genetic, epi...
Unselected population-based personalised ovarian cancer (OC) risk assessments combining genetic, epi...
BACKGROUND: We assessed ovarian cancer screening outcomes in women with a positive family history of...
Unselected population-based personalised ovarian cancer (OC) risk assessments combining genetic, epi...
Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk fo...
Aim: Ovarian cancer is one of the most common gynecologic cancers that has the highest mortality rat...
Epithelial ovarian cancer (EOC) is a heterogeneous disease with a major heritable component. The dif...
Background: Ovarian cancer (OC) is expected to cause 239,000 new cases and 152,000 deaths globally e...
Objective: Ovarian cancer is the leading cause of gynecological death in the United States, and 14% ...
This study assessed the sociodemographic, medical and psychological predictors of accuracy of percei...
Risk stratification using genetic and/or other types of information could identify women at increase...
Risk stratification using genetic and/or other types of information could identify women at increase...
Abstract Background Ovarian cancer is usually diagnosed at a late stage when outcomes are poor. Pers...
Background: In U.S. women, lifetime risk of ovarian cancer is 1.37%, but somewomen are at a substant...
Abstract Background Risk stratification using genetic and other types of personal information could ...
Unselected population-based personalised ovarian cancer (OC) risk assessments combining genetic, epi...
Unselected population-based personalised ovarian cancer (OC) risk assessments combining genetic, epi...
BACKGROUND: We assessed ovarian cancer screening outcomes in women with a positive family history of...
Unselected population-based personalised ovarian cancer (OC) risk assessments combining genetic, epi...
Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk fo...
Aim: Ovarian cancer is one of the most common gynecologic cancers that has the highest mortality rat...
Epithelial ovarian cancer (EOC) is a heterogeneous disease with a major heritable component. The dif...
Background: Ovarian cancer (OC) is expected to cause 239,000 new cases and 152,000 deaths globally e...
Objective: Ovarian cancer is the leading cause of gynecological death in the United States, and 14% ...